Navigation Links
Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B
Date:10/17/2011

OXFORD, England, October 18, 2011 /PRNewswire/ --

-- Third ocular product partnered with Sanofi approved to enter clinical development --

Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat®, a novel gene-based treatment for Usher syndrome type 1B.  UshStat® was designed and developed by Oxford BioMedica using the Company's proprietary LentiVector® platform technology and is the third programme to enter clinical development under the Phase I/II ocular collaboration agreement signed with Sanofi in April 2009.

The approval of the IND follows the decision by the US Recombinant DNA Advisory Committee (RAC) to approve the UshStat® Phase I/IIa protocol in May 2011.  The open label, dose escalation Phase I/IIa study will enrol up to 18 patients with Usher syndrome type 1B at the Oregon Health and Science University's Casey Eye Institute, Portland, Oregon.  The study, led by Professor Richard Weleber, will evaluate three dose levels for safety, tolerability and aspects of biological activity and is expected to be initiated by the end of 2011.

Usher syndrome is the most common form of deaf-blindness which affects approximately 30,000-50,000 patients in the US and Europe.  One of the most common subtypes is Usher syndrome type 1B.  The disease is caused by a mutation of the gene encoding myosin VIIA (MY07A), which leads to progressive retinitis pigmentosa combined with a congenital hearing defect.  UshStat® uses the Company's LentiVector® platform technology to deliver a corrected version of the MYO7A gene to address the vision loss associated with the disease.  O
'/>"/>

SOURCE Oxford BioMedica plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
2. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
3. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
4. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
5. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
6. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
7. Oxford BioTherapeutics Appoints Michael Moore as Chairman
8. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
9. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
10. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
11. Bavarian Nordics Case Against Oxford BioMedica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... of Illinois, Swanlund Chair Professor ... address on Monday, May 18 at the IEEE ... a week of more than 160 technical sessions that ... microwave technologies with health. Dr. Rogers, opening ... the Skin," will focus on the experimental and theoretical ...
(Date:3/30/2015)... 30, 2015 With recent advancements in ... the government, major companies are getting into the Solar ... future mandates for renewable energy production, many homeowners are ... Solara Power is a new solar distribution company in ... that allow qualifying homeowners to enjoy the benefits of ...
(Date:3/30/2015)... 30, 2015  New Jersey Health Foundation, a not-for-profit ... state of New Jersey , has ... funding, announced James M. Golubieski , president. ... Grants program, an additional $500,000 will be available for ... stage research projects that demonstrate exciting potential and may ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Solara Power Announces Residential Solar Power with No Up-Front Fees 2New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... Purdue University, working with the U.S. Air Force, have ... harsh conditions inside jet engines to detect when critical ... The devices are an example of an emerging technology ... machines that combine electronic and mechanical components on a ...
... Nabi,Biopharmaceuticals (Nasdaq: NABI ) (the "Company") announced ... Co., two of the nation,s leading,independent proxy advisory ... the Company,s proposed sale of its Biologics strategic,business ... Biotest,Pharmaceuticals Corporation, a wholly owned subsidiary of Biotest ...
... Bioscience, Inc., (http://www.pasteuriabio.com ), a Florida biotech company ... problem, announced,today that David N. Duncan, Ph.D., has ... Duncan has also been elected to the Company,s ... will remain active with the,Company as its Chief ...
Cached Biology Technology:Purdue creating wireless sensors to monitor bearings in jet engines 2Purdue creating wireless sensors to monitor bearings in jet engines 3RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 2RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 3Pasteuria Bioscience Taps New CEO David N. Duncan 2Pasteuria Bioscience Taps New CEO David N. Duncan 3
(Date:3/10/2015)...  Continuing its 167-year history of offering the Best, ... The Eye Scanning Password Authenticator , a device that ... websites or sensitive data. Employing the same ... the device has a small camera that scans and ... converting them into an encrypted ID that cannot be ...
(Date:3/10/2015)...   Tute Genomics , pioneer in affordable, accurate ... sequencing company PrimBio Research Institute to be ... panel interpretation. PrimBio, a certified Life Technologies ... technologies to support the work of experts on the ... types of exome sequencing services: 1) Targeted Exome and ...
(Date:3/5/2015)... -- In Brazil , cloud computing is ... solutions and 42 percent planning to invest in them by ... of the companies will be investing in these solutions for ... in the region are currently opting for the private cloud ... significant attention in the coming years. This trend is in ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... darkened meadow west of Boston, Tufts University biologists are ... life of fireflies. , For the first time, researchers ... light ?previously shown in one species to indicate superior ... to provide misinformation to prospective mates. In other words, ...
... mays) in Illinois, a field worker noticed a plant so ... species. Its "peculiarly shaped ear" was "laid aside as a ... Latin ramosus, "having many branches"). Due to the alteration of ... the tassel of the plant were more highly branched than ...
... at Nihon Nohyaku Co., Ltd., Bayer CropScience and DuPont ... show promise as a safer and more effective way ... insecticides, which represent the first synthetic compounds designed to ... may also help tackle the growing problem of insecticide ...
Cached Biology News:Tufts researchers shine light on firefly mysteries 2The genetic origins of corn on the cob 2Novel compounds show promise as safer, more potent insecticides 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood CD8+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: